30/06/2022at 13:47

Life science firms are planning USD 6.3bn construction spree in Denmark

Fujifilm’s expansion to its factory in Hillerød means that the life science sector has announced DKK 12bn (USD 1.7bn) in facility investments in Denmark since May.

Fujifilm's facility in Hillerød | Photo: Fujifilm Diosynth Biotechnologies / PR

by mikkel aabenhus hemmingsen, translated by catherine brett

Danish and international life science firms are the source of a veritable construction boom in Denmark.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

Access all locked articles
Receive our daily newsletters
Access our app

Get full access for you and your coworkers

Start a free company trial today

Fujifilm invests USD 1.5bn in Danish factory
For subscribers
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
For subscribers
Medicon Valley chair says Swedish growth ambitions will improve Danish life science
For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Front page now

Pharma & biotech

Adolescent patients' eczema improved in Leo Pharma's late-stage testing

Two phase III trials give the Danish dermatology company hope to see tralokinumab’s approved indication expanded to include the younger segment of teens.

For subscribers

Hearing health

DNB surprised by GN's lack of backup plan

For subscribers

Pharma & biotech

Leo Pharma presents positive data in hand eczema phase III trial

For subscribers

Foto: Guillaume Souvant/Reuters/Ritzau Scanpix

Pharma & biotech

Six-month Ozempic shortage mostly over after weight-loss craze drained supply

For subscribers

Foto: Tingshu Wang/Reuters/Ritzau Scanpix

Regulation

Competition sharpens on active ingredient production – EU weighs measures

For subscribers

Pharma & biotech

Wegovy prescriptions in the US grow for another week

For subscribers

Novo Nordisk: Life science power in EU industrial policy revision has been dimmed by Brexit

Europe’s life science industry relied heavily on UK leadership, says a Novo Nordisk representative, lamenting the loss of a pharmaceutical powerhouse when the EU revisits its industry policy.

For subscribers

Foto: Jacob Gronholt-Pedersen/Reuters/Ritzau Scanpix

Pharma & biotech

Novo Nordisk reacts to suspension: "We take the decision very seriously"

Novo Nordisk, which has been ousted from UK pharma group ABPI for two years, does not want to comment further on its punishment for misleading marketing.

For subscribers